Basic Materials
Privi Speciality Chemicals Limited Q4 FY26 Results: 40.9% Profit Growth
Explore Privi Speciality Chemicals Limited’s Q4 FY26 results showcasing a 40.9% profit growth, strategic vision, and future outlook.
Privi Speciality Chemicals Limited (PRIVISCL) has reported robust Q4 FY26 results, marking a significant 40.9% year-on-year profit growth. This impressive performance underscores the company’s strategic vision and operational excellence.
Financial Highlights
The company’s total income for the quarter stood at ₹725.70 crore, reflecting a 15.5% increase compared to the same period last year. The EBITDA surged by 25.1% to ₹184.41 crore, while the EBITDA margin improved to 25.4%. Notably, the profit after tax (PAT) grew by 40.9% to ₹93.7 crore, driven by strong operational performance and effective cost management.
Strategic Initiatives
During FY26, PRIVISCL undertook several strategic initiatives to support future growth. The company invested in debottlenecking projects to enhance capacity utilization and undertook focused investments in capability building for value-added and specialty products. These efforts have contributed to the company’s ability to deliver consistent performance and navigate external uncertainties with greater resilience.
Future Outlook
Looking ahead, PRIVISCL remains focused on disciplined execution and delivering on its 5k:1k vision over the medium term. The company’s emphasis on profitability and long-term value creation positions it well for sustained growth. With a strong emphasis on sustainability and responsible manufacturing, PRIVISCL is poised to continue its trajectory of prosperity with orderliness.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Privi Speciality Chemicals Limited
Privi Speciality Chemicals Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.
Privi gains 26.7% over three months and trades near its 52-week highs. Revenue grows at 14.3% and profits at 24.3% CAGR. The market consistently rewards this kind of compounding. Not a single revenue dip or loss quarter in five years — this is a business built to last through cycles. RSI hits 78, a level that signals the stock runs hot. Notably, buyers drove volume on 20 recent sessions — though at these levels, some profit-taking is normal. The business grows revenue at 14.3% and profits at 24.3%, with D/E of 1.04. The stock reflects that strength. Moreover, when fundamentals and price action align, the PEG of 1.86 premium is usually justified. Check Fundamentals of Privi Speciality Chemicals Limited.
ANURAS
Anupam Rasayan India Limited Completes Acquisition of Bliss GVS Pharma, Marks Third Strategic Step
Anupam Rasayan India Limited (ANURAS) completes acquisition of Bliss GVS Pharma, marking third strategic step towards building an integrated global pharma pl.
Anupam Rasayan India Limited (BSE: 543275, NSE: ANURAS), one of India’s leading custom synthesis and specialty chemical companies, has concluded the acquisition of a 48.2% controlling stake in Bliss GVS Pharma Limited at ₹299 per share, marking its third strategic inorganic transaction and expanding its presence into finished dosage formulations.
Strategic Milestone
The acquisition, undertaken through Mates Visa Consultancy, a wholly owned subsidiary of Anupam Rasayan, follows the definitive agreement signed on May 23, 2026, and the subsequent completion of the mandatory open offer process. With the acquisition now finalized, Bliss GVS Pharma becomes an integral part of Anupam Rasayan’s expanding portfolio of businesses across specialty chemicals and pharmaceuticals.
Financial and Operational Synergy
The transaction has been funded through a combination of a ₹300 crore term loan and approximately ₹1,450 crore raised through non-controlling, non-voting instruments from a group of financial investors led by Bain Capital and including Trust Group and Investec. The financing structure enables Anupam Rasayan to fund the acquisition while preserving balance-sheet capacity for future growth and expansion.
Future Growth Prospects
On the acquisition, Mr. Anand Desai, Managing Director of Anupam Rasayan India Ltd., said, “We are pleased to announce the successful completion of the acquisition of Bliss GVS Pharma. This transaction marks an important milestone in our long-term strategy to build a diversified, integrated and innovation-led global pharmaceutical platform. The acquisition strengthens our presence in finished pharmaceutical formulations and complements Anupam Rasayan’s expertise in key starting materials, intermediates and specialty chemicals.”
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Anupam Rasayan India Limited
Anupam Rasayan India Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.
Anupam moves sideways over three months, with neither buyers nor sellers taking control. Thin margins at 6.9% leave limited room for error — any demand softness or cost spike hits the bottom line hard. No meaningful dividend — total return is entirely dependent on capital appreciation. Sellers drive 1.8x the volume of buyers. Furthermore, they controlled 17 of recent sessions versus 13 for buyers — a clear distribution signal. Revenue grows at 14.1% yet the PEG reaches 99.00 — expensive for that growth. Furthermore, the stock drops 6.1% in three months. Neither value nor momentum supports this setup. It needs an earnings beat or a price reset first. Check Fundamentals of Anupam Rasayan India Limited.
Aluminum
National Aluminium Company Limited (nationalum) Announces Record Dividend Payment for FY 2025-26
National Aluminium Company Limited (NATIONALUM) pays ₹1,083.06 crore dividend to Government of India for FY 2025-26, marking highest-ever payout.
National Aluminium Company Limited (NATIONALUM) has made headlines today by announcing a record dividend payment of ₹1,083.06 crore to the Government of India for FY 2025-26. This marks the highest-ever dividend paid by the company, reflecting its robust financial performance for the year. The dividend cheque was handed over to Shri G. Kishan Reddy, Hon’ble Union Minister of Coal & Mines, Government of India, during an Investor Roadshow on Angul Aluminium Park held in Kolkata today.
Record-Breaking Dividend
The total dividend paid by NATIONALUM for FY 2025-26 amounts to ₹2,112.12 crore, which includes three interim dividends and a final dividend. This significant payout underscores the company’s commitment to returning value to its shareholders and the government. The robust performance in FY 2025-26 saw a Profit After Tax (PAT) of ₹5,815.76 crore, highlighting the company’s strong financial health and operational efficiency.
Strategic Investment Roadshow
The announcement came during an Investor Roadshow organized by NATIONALUM in association with Odisha Industrial Infrastructure Development Corporation (IDCO) at Angul Aluminium Park in Kolkata. The event aimed to showcase investment opportunities in downstream and value-added aluminium manufacturing. Shri Jagdish Arora, Director (P&T), NATIONALUM, welcomed the attendees and emphasized the investor-friendly ecosystem that supports employment generation and industrial growth.
As a result, the Angul Aluminium Park is poised to become a pivotal platform for establishing and expanding aluminium-based manufacturing operations, fostering innovation, and contributing to India’s vision of building a self-reliant and developed nation.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of National Aluminium Company Limited
National Aluminium Company Limited belongs to the Basic Materials › Aluminum sector. Here’s a quick read on where the business and the stock stand today.
National posts a 2.8% three-month gain, but softens in the last few weeks. The PEG of 0.16 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Industry-leading margins of 34.9% reflect exceptional pricing power and operational efficiency. The stock gives back 11.6% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 7.8% and profits at 59.3%. The business is in good shape. Moreover, a stock that does not move despite strong fundamentals often offers better value than one already priced for perfection. Check Fundamentals of National Aluminium Company Limited.
Basic Materials
Ellenbarrie Industrial Gases Limited Secures ₹481 Crore Air Separation Unit Contract
Ellenbarrie Industrial Gases Limited secures a ₹481 crore contract for a 1200 TPD Air Separation Unit from BHEL for its Coal to Ammonium Nitrate project.
Ellenbarrie Industrial Gases Limited (ELLEN) today announced securing a ₹481 crore contract for a 1200 TPD cryogenic Air Separation Unit (ASU) from Bharat Heavy Electricals Ltd. (BHEL) for its Coal to Ammonium Nitrate (2000TPD) project. This marks a significant milestone for ELLEN as it enters one of India’s largest long-term industrial gas opportunities under the National Coal Gasification Mission. The contract includes design, engineering, supply, erection, testing, pre-commissioning, commissioning, trial runs operation, operator training, demonstration of performance guarantees, supply of spares, and handing over, all on a turnkey basis. The project will be executed over eight quarters and is expected to be commissioned in FY29.
Strategic Project Under National Coal Gasification Mission
This contract is part of India’s broader push towards coal gasification, a strategic national initiative aimed at reducing import dependence while creating domestic production capacity for chemicals, fertilisers, and clean industrial feedstocks. The Government of India has outlined an ambitious vision of gasifying 100 million tonnes of coal annually by 2030, with coal gasification expected to support domestic production of ammonia, urea, methanol, hydrogen, and other downstream chemicals.
Significant Milestone for ELLEN
Commenting on the development, Varun Agarwal, Joint Managing Director of ELLEN, said: ‘This order represents an important strategic milestone for ELLEN as we strengthen our participation in India’s emerging coal gasification ecosystem. While this is a Build and Transfer project, it recognises our capability to deliver large-scale cryogenic Air Separation Units for complex industrial applications. As India’s coal gasification programme gathers momentum over the coming years, we believe our engineering expertise, execution track record, and deep experience in industrial gases position us well to participate in this long-term growth opportunity.’ This contract will be the largest plant built by ELLEN till date and takes the company into an exclusive list of companies having the capability of building plants of more than 1000 TPD.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Ellenbarrie Industrial Gases Limited
Ellenbarrie Industrial Gases Limited belongs to the Basic Materials › Chemicals sector. Here’s a quick read on where the business and the stock stand today.
Ellenbarrie rises 35.6% over three months, with buying pressure holding steady. The PEG of 0.76 signals undervaluation relative to growth. It is a potential re-rating candidate. Industry-leading margins of 33.8% reflect exceptional pricing power and operational efficiency. Buyers show up with 2.2x the volume of sellers. Moreover, they dominated on 17 of recent sessions versus 13 for sellers — a healthy accumulation pattern. Both the business and the stock move in the right direction. Revenue grows at 16.9%, profits at 54.8%, and the PEG sits at 0.76 — below its growth rate. That combination is rare. Check Fundamentals of Ellenbarrie Industrial Gases Limited.
-
Healthcare3 days agoZydus Lifesciences Limited (zyduslife) USFDA Inspection of Pharmacovigilance Concludes with Nil Observations
-
Beverages - Brewers3 days agoSom Distilleries & Breweries Limited (sdbl): Court Judgment Clears Path for Licence Renewal
-
Solar3 days agoSwelect Energy Systems Limited Expands C&I Energy Solutions Portfolio with Rollout of SWEES EN+ Solar Hybrid Inverter Range
-
AUGMONT3 days agoAugmont Enterprises Limited (augmont) Empanelled by NSE for Promotion of Electronic Gold Receipts (EGR)
-
Healthcare22 hours agoLupin Limited (lupin) Receives Tentative FDA Approval for Apixaban Oral Suspension
-
Consumer Defensive22 hours agoRadico Khaitan Limited Expands Global Reach: Indian Luxury Whisky Brands Land in the Home of Scotch
-
Healthcare23 hours agoSun Pharmaceutical Industries Limited (sunpharma) Secures Global Licensing for Lerodalcibep, a PCSK9 Inhibitor
-
Capital Markets22 hours agoIndian Energy Exchange Limited Expands Energy Markets Footprint